Cardiac muscarinic receptors decrease with age: In vitro and in vivo studies

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 471-478

  Brodde, Otto Erich ^a   Konschak, Ulrich ^a   Becker, Karin ^a   Rüter, Florian ^a   Poller, Ulrike ^a   Jakubetz, Jens ^a   Radke, Joachim ^a   Zerkowski, Hans Reinhard ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adenylyl cyclase; Aging; Heart rate; Heart transplantation; Human cardiac muscarinic receptors

Indexed keywords

ACETYLSALICYLIC ACID; ADENYLATE CYCLASE; AZATHIOPRINE; CARBACHOL; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISOPRENALINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; NITRATE; PIRENZEPINE; PREDNISOLONE;

ACETYLCHOLINE RELEASE; ADULT; AGED; ARTICLE; HEART RATE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INHIBITION KINETICS; MALE; NORMAL HUMAN; OPEN HEART SURGERY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR DENSITY; RECEPTOR GENE;

EID: 0032518301     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1113     Document Type: Article

References (43)

1. Roth, G.S. 1979. Hormone receptor changes during adulthood and senescence: significance for aging research. Fed. Proc. 38:1910-1914.
2. Docherty, J.R. 1990. Cardiovascular responses in aging: a review. Pharmacol. Rev. 42:103-125.
3. Lakatta, E.G. 1993. Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 73:413-467.
4. Folkow, B., and A. Svanborg. 1993. Physiology of cardiovascular aging. Physiol. Rev. 73:725-764.
5. Giraldo, E., F. Martos, A. Gomez, A. Garcia, M.A. Vigano, H. Ladinsky, and F. Sanchez de la Cuesta. 1988. Characterization of muscarinic receptor subtypes in human tissues. Life Sci. 43:1507-1515.
6. Deighton, N.M., S. Motomura, D. Borquez, H.-R. Zerkowski, N. Doetsch, and O.-E. Brodde. 1990. Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:414-421.
7. i in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 82:1249-1265.
8. Von Scheidt, W., M. Böhm, A. Stäblein, G. Autenrieth, and E. Erdmann. 1992. Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivo. Am. J. Physiol. 263:H1927-H1931.
9. Landzberg, J.S., J.D. Parker, D.F. Gauthier, and W.S. Colucci. 1994. Effect of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 89:164-168.
10. Poller, U., G. Nedelka, J. Radke, K. Pönicke, and O.-E. Brodde. 1997. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J. Am. Coll. Cardiol. 29:187-193.
11. 1-adrenoceptor antagonist treatment. J. Am. Coll. Cardiol. 23:1224-1233.
12. Poller, U., R.F. Schäfers, S. Schmuck, J. Jakubetz, J. Radke, A.E. Daul, K. Pönicke, and O.-E. Brodde. 1997. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:100-106.
13. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
14. Salomon, Y., C. Londos, and M. Rodbell. 1974. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548.
15. Brodde, O.-E., H.-R. Zerkowski, D. Schranz, A. Broede-Sitz, M. Michel-Reher, E. Schäfer-Beisenbusch, J.A. Piotrowski, and H. Oelert. 1995. Age-dependent changes of the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J. Cardiovasc. Pharmacol. 26:20-26.
16. Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660-672.
17. Winer, B.J., D.R. Brown, and K.M. Michels. 1991. Statistical Principles in Experimental Design. McGraw-Hill Inc., New York. 907 pp.
18. 2-cholinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:19-27.
19. 2-cholinoceptor occupancy. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:207-210.
20. Eglen, R.M., and N. Watson. 1996. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78:59-68.
21. Pitschner, H.F., M. Schlepper, B. Schulte, C. Volz, D. Palm, and A. Wellstein. 1989. Selective antagonists reveal different functions of M cholinoceptor subtypes in humans. Trends Pharmacol. Sci. 10(Suppl.):92-96.
22. Jeck, D., R. Lindmar, K. Löffelholz, and M. Wanke. 1988. Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea-pig hearts. Br. J. Pharmacol. 93:357-366.
23. Brehm, G., R. Lindmar, and K. Löffelholz. 1992. Inhibitory and excitatory muscarinic receptors modulating the release of acetylcholine from the postganglionic parasympathetic neuron of the chicken heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:375-382.
24. Bognar, I.T., B. Beinhauer, P. Kann, and H. Fuder. 1990. Different muscarinic receptors mediate autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat isolated perfused heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:279-287.
25. 1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:483-489.
26. Epstein, A.E., B.I. Hirschowitz, J.K. Kirklin, K.A. Kirk, G.N. Kay, and V.J. Plumb. 1990. Evidence for a central site of action to explain the negative chronotropic effect of atropine: studies on the human transplanted heart. J. Am. Coll. Cardiol. 15:1610-1617.
27. Wilson, R.F., B.V. Christensen, and A. Simon. 1991. Evidence for structural sympathetic reinnervation after human orthotopic cardiac transplantation. Circulation. 83:1210-1220.
28. Koglin, J., T. Gross, P. Überfuhr, and W. Von Scheidt. 1997. Time-dependent decrease of presynaptic inotropic supersensitivity: physiological evidence of sympathetic reinnervation after heart transplantation. J. Heart Lung Transplant. 16:621-628.
29. Frey, A.W., M. Dambacher, H. Achakri, M. Schwaiger, P. Überfuhr, G. Spadacini, L. Bernardi, and H. Roskamm. 1997. First evidence of parallel vagal and sympathetic reinnervation long term after heart transplantation. J. Heart Lung Transplant. 16:88. (Abstr.)
30. Brodde, O.-E., S. Hillemann, K. Kunde, M. Vogelsang, and H.-R. Zerkowski. 1992. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J. Heart Lung Transplant. 11: S164-S174.
31. Bristow, M.R. 1993. Changes in myocardial and vascular receptors in heart failure. J. Am. Coll. Cardiol. 22(Suppl. 4):61A-71A.
32. Levy, M.N. 1971. Sympathetic-parasympathetic interactions in the heart. Circ. Res. 29:437-145.
33. Koglin, J., M. Böhm, W. Von Scheidt, A. Stäblein, and E. Erdmann. 1994. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo. J. Am. Coll. Cardiol. 23:678-683.
34. Newton, G.E., A.B. Parker, J.S. Landzberg, W.S. Colucci, and J.D. Parker. 1996. Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle. J. Clin. Invest. 98:2756-2763.
35. Kent, K.M., S.E. Epstein, T. Cooper, and D.M. Jacobowitz. 1974. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation. 50:948-955.
36. Löffelholz, K., and A.J. Pappano. 1985. The parasympathetic neuroeffector junction of the heart. Pharmacol. Rev. 37:1-24.
37. Fields, J.Z., W.R. Roeske, F. Morkin, and H.I. Yamamura. 1978. Cardiac muscarinic cholinergic receptors, biochemical identification and characterization. J. Biol. Chem. 253:3251-3258.
38. Sorota, S., L.P. Adam, and A.J. Pappano. 1986. Comparison of muscarinic receptor properties in hatched chick heart atrium and ventricle. J. Pharmacol. Exp. Ther. 236:602-609.
39. Feldman, R.D. 1986. Physiological and molecular correlates of age-related changes in the human β-adrenergic receptor system. Fed. Proc. 45:48-50.
40. White, M., R. Roden, W. Minobe, M.F. Khan, P. Larrabee, M. Wollmering, D. Port, F. Anderson, D. Campbell, A.M. Feldman, and M.R. Bristow. 1994. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation., 90:1225-1238.
41. Arnold, J.M.O., and D.G. McDevitt. 1984. Vagal activity is increased during intravenous isoprenaline infusion in man. Br. J. Clin. Pharmacol. 18: 311-316.
42. White, M., and F.H.H. Leenen. 1994. Aging and cardiovascular responsiveness to β-agonist in humans: role of changes in β-receptor responses versus baroreflex activity. Clin. Pharmacol. Ther. 56:543-553.
43. Pfeifer, M.A., C.R. Weinberg, D. Cook, J.D. Best, A. Reenan, and J.B. Halter. 1983. Differential changes of autonomic nervous system function with age in man. Am. J. Med. 75:249-258.